Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ACTRN12626000709347) titled 'C-IMPACT: A phase 1 PET-CT study to evaluate the safety, biodistribution and pharmacokinetics of 89Zrhu/mo-10D7 in locally advanced or distant metastatic CDCP1 positive epithelial cancers' on June 12.
Study Type: Interventional
Study Design:
Purpose: Diagnosis
Allocation: Non-randomised trial
Primary Sponsor: Mater Hospital
Condition:
Ovarian Cancer
Bladder Cancer
Breast Cancer
Pancreatic Cancer
Ovarian Cancer
Bladder Cancer
Breast Cancer
Pancreatic Cancer
Cancer - Bladder
Cancer - Breast
Cancer - Pancreatic
Cancer - Ovarian and primary peritoneal
Intervention:
Participants will receive a single dos...